Detalhe da pesquisa
1.
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial.
Ann Intern Med
; 174(2): 145-156, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284677
2.
Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.
Alzheimers Dement
; 15(11): 1427-1436, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587995
3.
R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
Br J Clin Pharmacol
; 82(3): 784-92, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27145364
4.
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
J Geriatr Psychiatry Neurol
; 29(2): 59-64, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303700
5.
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
Ophthalmology
; 122(10): 1967-75, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26298715
6.
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
Am J Geriatr Psychiatry
; 23(11): 1127-33, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26238225
7.
Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.
Int Psychogeriatr
; 27(12): 2059-67, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26305876
8.
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.
Ophthalmology
; 121(10): 1855-62, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24908205
9.
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
Am J Geriatr Psychiatry
; 22(1): 14-24, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24314887
10.
The transitioning from trials to extended follow-up studies.
Clin Trials
; 11(6): 635-47, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25115882
11.
Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial.
Int Psychogeriatr
; 26(2): 239-46, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24169147
12.
Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.
JAMA
; 311(7): 682-91, 2014 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24549548
13.
Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.
Clin Infect Dis
; 57(11): 1618-25, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081683
14.
Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).
Am J Geriatr Psychiatry
; 21(6): 549-59, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23567407
15.
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
Am J Geriatr Psychiatry
; 20(12): 1036-44, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23032478
16.
Citalopram for agitation in Alzheimer's disease: design and methods.
Alzheimers Dement
; 8(2): 121-30, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22301195
17.
Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
J Geriatr Psychiatry Neurol
; 24(4): 222-8, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22228829
18.
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
Int J Geriatr Psychiatry
; 26(6): 573-83, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20672243
19.
Sertraline for the treatment of depression in Alzheimer disease.
Am J Geriatr Psychiatry
; 18(2): 136-45, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20087081
20.
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
Am J Geriatr Psychiatry
; 18(4): 332-40, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20220589